ReviewFrontiers in pharmacology2022

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.

Luyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.